Experts share their insight on screening, treatment, clinical trials and more
April 14, 2015
| By Susan Keown / Fred Hutch News Service
On Saturday, prostate cancer experts shared their knowledge about screening, treatment and clinical trials at the fourth annual symposium for patients and families held at Fred Hutchinson Cancer Research Center. The event was hosted by the Institute for Prostate Cancer Research ― a joint program of Fred Hutch and UW Medicine. To help distill the latest recommendations and research, here are six things men need to know.
Daniel Lin study shows two biomarkers in urine are associated with cancers likely to be aggressive among men who take a 'watchful waiting' approach
Feb. 6, 2012
| By Kristen Woodward
Initial results of a multicenter study coordinated by Hutchinson Center researchers indicates that two investigational urine-based biomarkers are associated with prostate cancers that are likely to be aggressive and potentially life-threatening among men who take a "watchful waiting," or active-surveillance, approach to manage their disease. Ultimately, these markers may lead to the development of a urine test that could complement prostate biopsy for predicting disease aggressiveness and progression.
Seattle Cancer Care Alliance physicians design University of Washington-based study to examine association between age at prostate-cancer diagnosis and health outcomes
June 8, 2009
To investigate the impact of age on prostate-cancer prognosis, Drs. Daniel Lin and Bruce Montgomery of the Seattle Cancer Care Alliance and University of Washington colleague Michael Porter designed a study at the UW to examine the association between age at diagnosis and health outcomes in men diagnosed with prostate cancer in the U.S.